Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.

Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, Thiel FC, Hartmann A, Wachter DL, Anglesio MS, Høgdall E, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Fogarty ZC, Vierkant RA, Liu S, Cho S, Nelson G, Ghatage P, Gentry-Maharaj A, Gayther SA, Benjamin E, Widschwendter M, Intermaggio MP, Rosen B, Bernardini MQ, Mackay H, Oza A, Shaw P, Jimenez-Linan M, Driver KE, Alsop J, Mack M, Koziak JM, Steed H, Ewanowich C, DeFazio A, Chenevix-Trench G, Fereday S, Gao B, Johnatty SE, George J, Galletta L; AOCS Study Group, Goode EL, Kjær SK, Huntsman DG, Fasching PA, Moysich KB, Brenton JD, Kelemen LE.

Br J Cancer. 2014 Dec 9;111(12):2297-307. doi: 10.1038/bjc.2014.567. Epub 2014 Oct 30.

2.

CYP2D6 gene variants and their association with breast cancer susceptibility.

Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Earl HM, Dunning AM, Pharoah PD, Caldas C.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1255-8. doi: 10.1158/1055-9965.EPI-11-0321. Epub 2011 Apr 28.

3.

CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen.

Abraham JE, Maranian MJ, Driver KE, Platte R, Kalmyrzaev B, Baynes C, Luccarini C, Shah M, Ingle S, Greenberg D, Earl HM, Dunning AM, Pharoah PD, Caldas C.

Breast Cancer Res. 2010;12(4):R64. doi: 10.1186/bcr2629. Epub 2010 Aug 23.

4.

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.

Dawson SJ, Makretsov N, Blows FM, Driver KE, Provenzano E, Le Quesne J, Baglietto L, Severi G, Giles GG, McLean CA, Callagy G, Green AR, Ellis I, Gelmon K, Turashvili G, Leung S, Aparicio S, Huntsman D, Caldas C, Pharoah P.

Br J Cancer. 2010 Aug 24;103(5):668-75. doi: 10.1038/sj.bjc.6605736. Epub 2010 Jul 27. Erratum in: Br J Cancer. 2010 Sep 28;103(7):1137.

5.

No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, Brown J, Audley T, McGuffog L, Ponder BA, Pharoah PD, Easton DF, Dunning AM.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1862-5. doi: 10.1158/1055-9965.EPI-10-0281. Epub 2010 Jun 22.

6.

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.

Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkilä P, Heikkinen T, Nevanlinna H, Akslen LA, Bégin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, Anderson WF, Cox A, Cross SS, Reed MW, Provenzano E, Dawson SJ, Dunning AM, Humphreys M, Easton DF, García-Closas M, Caldas C, Pharoah PD, Huntsman D.

PLoS Med. 2010 May 25;7(5):e1000279. doi: 10.1371/journal.pmed.1000279.

7.

Telomere length in prospective and retrospective cancer case-control studies.

Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, Easton DF, Dunning AM.

Cancer Res. 2010 Apr 15;70(8):3170-6. doi: 10.1158/0008-5472.CAN-09-4595.

8.

Familial relative risks for breast cancer by pathological subtype: a population-based cohort study.

Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D, Macinnis RJ, Shah M; SEARCH Team, Easton DF, Antoniou AC.

Breast Cancer Res. 2010;12(1):R10. doi: 10.1186/bcr2476. Epub 2010 Feb 10.

9.

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.

Dawson SJ, Duffy SW, Blows FM, Driver KE, Provenzano E, LeQuesne J, Greenberg DC, Pharoah P, Caldas C, Wishart GC.

Br J Cancer. 2009 Oct 20;101(8):1338-44. doi: 10.1038/sj.bjc.6605317. Epub 2009 Sep 22.

10.

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

Azzato EM, Greenberg D, Shah M, Blows F, Driver KE, Caporaso NE, Pharoah PD.

Br J Cancer. 2009 Jun 2;100(11):1806-11. doi: 10.1038/sj.bjc.6605062. Epub 2009 Apr 28.

11.

Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.

Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD.

Clin Cancer Res. 2009 Mar 15;15(6):2181-91. doi: 10.1158/1078-0432.CCR-08-0716. Epub 2009 Mar 10.

12.

Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.

Pooley KA, Baynes C, Driver KE, Tyrer J, Azzato EM, Pharoah PD, Easton DF, Ponder BA, Dunning AM.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3482-9. doi: 10.1158/1055-9965.EPI-08-0594.

13.

Multiple loci with different cancer specificities within the 8q24 gene desert.

Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators.

J Natl Cancer Inst. 2008 Jul 2;100(13):962-6. doi: 10.1093/jnci/djn190. Epub 2008 Jun 24.

14.

Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.

Azzato EM, Driver KE, Lesueur F, Shah M, Greenberg D, Easton DF, Teschendorff AE, Caldas C, Caporaso NE, Pharoah PD.

Breast Cancer Res. 2008;10(3):R47. doi: 10.1186/bcr2100. Epub 2008 May 28.

15.

The association between cheese consumption and cardiovascular risk factors among adults.

Houston DK, Driver KE, Bush AJ, Kritchevsky SB.

J Hum Nutr Diet. 2008 Apr;21(2):129-40. doi: 10.1111/j.1365-277X.2008.00853.x.

PMID:
18339053
16.

Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.

Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BA, Easton DF, Pharoah PD, Dunning AM; Studies in Epidemiology and Risks of Cancer Heredity (SEARCH) Team.

Carcinogenesis. 2008 Feb;29(2):333-41. doi: 10.1093/carcin/bgm284. Epub 2008 Jan 3.

Supplemental Content

Loading ...
Support Center